Phospho-YAP1 (S127) Recombinant Rabbit Monoclonal Antibody [SN0718]
Usd: 385 Special Discount
Specification
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_ET1611-69_Europe.pdf
- No MSDS Found
Overview
Product Name
Phospho-YAP1 (S127) Recombinant Rabbit Monoclonal Antibody [SN0718]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic phospho-peptide corresponding to residues surrounding Ser127 of human YAP1.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IHC-P
Target Molecular Weight
Predicted band size: 54 kDa
Positive Control
HeLa treated with 100nM Calyculin A for 30 minutes whole cell lysate, NIH/3T3 treated with 100nM Calyculin A for 30 minutes whole cell lysate, C6 treated with 100nM Calyculin A for 30 minutes whole cell lysate, human kidney tissue, mouse kidney tissue, rat kidney tissue.
Conjugation
unconjugated
Clone Number
SN0718
RRID
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:5,000
-
IHC-P
-
1:2,000-1:5,000
Target
Function
The Yes-associated protein, otherwise known as YAP, is a 14-3-3-binding molecule that was originally recognized by virtue of its ability to bind to the SH3 domain of Yes. The binding of YAP to 14-3-3 requires the phosphorylation of a homologous serine residue (Ser 112) in the YAP 14-3-3-binding motif. The highly conserved and ubiquitously expressed 14-3-3 proteins regulate differentiation, cell cycle progression and apoptosis by binding intracellular phosphoproteins involved in signal transduction. YAP may link events at the plasma membrane and cytoskeleton to inhibition of transcription in the nucleus in a manner regulated by 14-3-3 proteins. YAP shares homology with the WW domain of TAZ, transcriptional co-activator with PDZ-binding motif, which functions as a transcriptional co-activator by binding to the PPXY motif present in transcription factors. YAP is expressed at high levels in the lung, placenta, prostate, ovary and testis.
Background References
1. Ye L et al. Decreased Yes-Associated Protein-1 (YAP1) Expression in Pediatric Hearts with Ventricular Septal Defects. PLoS One 10:e0139712 (2015).
2. Whiteman EL et al. Crumbs3 is essential for proper epithelial development and viability. Mol Cell Biol 34:43-56 (2014).
Sequence Similarity
Belongs to the YAP1 family.
Tissue Specificity
Increased expression seen in some liver and prostate cancers. Isoforms lacking the transactivation domain found in striatal neurons of patients with Huntington disease (at protein level).
Post-translational Modification
Phosphorylated by LATS1 and LATS2; leading to cytoplasmic translocation and inactivation. Phosphorylated by ABL1; leading to YAP1 stabilization, enhanced interaction with TP73 and recruitment onto proapoptotic genes; in response to DNA damage. Phosphorylation at Ser-400 and Ser-403 by CK1 is triggered by previous phosphorylation at Ser-397 by LATS proteins and leads to YAP1 ubiquitination by SCF(beta-TRCP) E3 ubiquitin ligase and subsequent degradation. Phosphorylated at Thr-119, Ser-138, Thr-154, Ser-367 and Thr-412 by MAPK8/JNK1 and MAPK9/JNK2, which is required for the regulation of apoptosis by YAP1.; Ubiquitinated by SCF(beta-TRCP) E3 ubiquitin ligase.
Subcellular Location
Cytoplasm, Nucleus.
Synonyms
65 kDa Yes associated protein antibody
65 kDa Yes-associated protein antibody
COB1 antibody
YAp 1 antibody
YAP 65 antibody
YAP antibody
YAP1 antibody
YAP1_HUMAN antibody
YAP2 antibody
YAP65 antibody
Expand65 kDa Yes associated protein antibody
65 kDa Yes-associated protein antibody
COB1 antibody
YAp 1 antibody
YAP 65 antibody
YAP antibody
YAP1 antibody
YAP1_HUMAN antibody
YAP2 antibody
YAP65 antibody
yes -associated protein delta antibody
Yes associated protein 1 65kDa antibody
Yes associated protein 1 antibody
Yes associated protein 2 antibody
yes associated protein beta antibody
YKI antibody
Yorkie homolog antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of Phospho-YAP1 (S127) on different lysates with Rabbit anti-Phospho-YAP1 (S127) antibody (ET1611-69) at 1/5,000 dilution and competitor's antibody at 1/1,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: HeLa treated with 100nM Calyculin A for 30 minutes cell lysate
Lane 3: C6 cell lysate
Lane 4: C6 treated with 100nM Calyculin A for 30 minutes cell lysate
Lane 5: NIH/3T3 cell lysate
Lane 6: NIH/3T3 starved for 24 hours then treated with 100nM Calyculin A for 30 minutes cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 54 kDa
Observed band size: 70 kDa
Exposure time: 50 seconds; ECL: K1802;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1611-69) at 1/5,000 dilution and competitor's antibody at 1/1,000 dilution were used in 5% BSA at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Western blot analysis of Phospho-YAP1 (S127) on different lysates with Rabbit anti-Phospho-YAP1 (S127) antibody (ET1611-69) at 1/5,000 dilution.
Lane 1: HeLa whole cell lysate
Lane 2: HeLa treated with 100nM Calyculin A for 30 minutes whole cell lysate
Lane 3: HeLa treated with 100nM Calyculin A for 30 minutes then treated with λpp for 1 hour whole cell lysate
Lane 4: NIH/3T3 whole cell lysate
Lane 5: NIH/3T3 treated with 100nM Calyculin A for 30 minutes whole cell lysate
Lane 6: NIH/3T3 treated with 100nM Calyculin A for 30 minutes then treated with λpp for 1 hour whole cell lysate
Lane 7: C6 whole cell lysate
Lane 8: C6 treated with 100nM Calyculin A for 30 minutes whole cell lysate
Lane 9: C6 treated with 100nM Calyculin A for 30 minutes then treated with λpp for 1 hour whole cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 54 kDa
Observed band size: 70 kDa
Exposure time: 1 minute 6 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1611-69) at 1/5,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:100,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Rabbit anti-Phospho-YAP1 (S127) antibody (ET1611-69) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1611-69) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Rabbit anti-Phospho-YAP1 (S127) antibody (ET1611-69) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1611-69) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat kidney tissue with Rabbit anti-Phospho-YAP1 (S127) antibody (ET1611-69) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1611-69) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
RNF207 promotes colorectal cancer growth by regulating the Hippo–YAP pathway via enhanced MST1 ubiquitination and degradation
Journal: Journal of Gastroenterology
DOI: 10.1007/s00535-026-02440-2
IF: 5.7
Application: IHC
Reactivity: Human
Publish date: 2026 May
-
Osteoblast-derived osteomodulin restrains osteoclastogenesis via ITGB8/RRM2-mediated reduction of mitochondrial respiration and mitochondrial ATP production
Journal: Experimental & Molecular Medicine
DOI: 10.1038/s12276-026-01682-7
IF: 12.9
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Impact of ventricular pressure load changes on cardiomyocyte proliferation: the role of ALDH2 and GRAF1
Journal: Biochimica et Biophysica Acta - Molecular Cell Research
DOI: 10.1016/j.bbamcr.2026.120173
IF: 4.3
Application: WB
Reactivity: Mouse
Publish date: 2026 Jun
-
SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts
Journal: Cancer Research
DOI: 10.1158/0008-5472.CAN-24-4916
IF: 16.6
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
The Herbal Compound Miltirone from Salvia miltiorrhiza Targets DJ-1 to Induce Mitophagic Dysfunction and ROS-Dependent Hippo Activation in Gastric Cancer
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.157821
IF: 8.3
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Vitamin D receptor isoform VDRA suppresses hepatocellular tumorigenesis by restricting YAP nuclear localization
Journal: Cell Death & Disease
DOI: 10.1038/s41419-026-08792-0
IF: 9.6
Application: WB
Reactivity: Human
Publish date: 2026 Apr
-
The potential of TAOK1 as a new therapeutic target for the treatment of cancer cachexia-associated muscle atrophy
Journal: Pharmacological Research
DOI: 10.1016/j.phrs.2025.107763
IF: 9.1
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma
Journal: Cell Death & Disease
DOI: 10.1038/s41419-025-07745-3
IF: 9.6
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jun
-
Vitamin D ameliorates prediabetic cardiac injure via modulation of the ErbB4/ferroptosis signaling axis
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2025.1626295
IF: 5.9
Application: WB
Reactivity: Mouse,Rat
Publish date: 2025 Jul
-
Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma
Journal: Cell Death & Disease
DOI: 10.1038/s41419-025-07412-7
IF: 8.1
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
Rinsenoside Rg1 and its involvement in Hippo–YAP signaling pathway alleviating symptoms of depressive-like behavior
Journal: Scientific Reports
DOI: 10.1038/s41598-025-99587-4
IF: 3.8
Application: WB
Reactivity: Mouse,Rat
Publish date: 2025 Apr
-
Macrophage-derived amphiregulin promoted the osteogenic differentiation of chondrocytes through EGFR/Yap axis and TGF-β activation
Journal: Bone
DOI:
IF: 3.5
Application: WB
Reactivity: Mouse
Publish date: 2024 Oct
-
Cyclic tensile stress promotes osteogenic differentiation via upregulation of Piezo1 in human dental follicle stem cells
Journal: Human Cell
DOI:
IF: 3.4
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
ANNEXIN A2 FACILITATES NEOVASCULARIZATION TO PROTECT AGAINST MYOCARDIAL INFARCTION INJURY VIA INTERACTING WITH MACROPHAGE YAP AND ENDOTHELIAL INTEGRIN Β3
Journal: Shock
DOI:
IF: 3.1
Application: WB
Reactivity: Mouse
Publish date: 2023 Oct
-
GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization
Journal: Oncology Letters
DOI: 10.3892/ol.2023.14131
IF: 2.9
Application: WB
Reactivity: Human
Publish date: 2023 Nov
-
Abnormal mechanical stress induced chondrocyte senescence by YAP loss-mediated METTL3 upregulation
Journal: Oral Diseases
DOI: 10.1111/odi.14810
IF: 3.8
Application: IHC-P
Reactivity: Rat
Publish date: 2023 Nov
-
Intermittent Hydrostatic Pressure Promotes Cartilage Repair in an Inflammatory Environment through Hippo-YAP Signaling In Vitro and In Vivo
Journal: Biomed Research International
DOI:
IF: 3.246
Application: WB,IHC-P
Reactivity: Rat
Publish date: 2022 Aug
-
Aqueous extract of Taxus chinensis var. mairei regulates the Hippo-YAP pathway and promotes apoptosis of non-small cell lung cancer via ATF3 in vivo and in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 138, 111506.
Journal: Biomedicine & Pharmacotherapy
DOI:
IF: 4.545
Application: WB
Reactivity: Mouse,Human
Publish date: 2021 Jun